CytomX Therapeutics (CTMX) Analyst & Key Data

Analyst Consensus

Buy10 analysts

Buy

Updated Sep 12, 2026

Total Analysts10

Buy

17

Hold

4

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score1.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$3.29

Median Target+181.16%

$9.25

Potential upside vs current price

Current Stock Price

$3.29

Median Target+181.16%

$9.25

Potential upside vs current price

Analyst Consensus

Buy10 analysts

Buy

Updated Sep 12, 2026

Total Analysts10

Buy

17

Hold

4

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score1.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$3.29

Median Target+181.16%

$9.25

Potential upside vs current price

Current Stock Price

$3.29

Median Target+181.16%

$9.25

Potential upside vs current price

CytomX Therapeutics, Inc.